Osteoporosis is a common disease in which loss of bone mass results in skeletal fragility. The development of therapies for this disorder has been hampered by the lack of a convenient animal model. Here we describe a disorder in bone homeostasis in transgenic mice that inappropriately express the cytokine interleukin 4 (IL-4) under the direction of the lymphocyte-specific proximal promoter for the kck gene. Bone disease in Ick-IL-4 mice appeared to result from markedly decreased bone formation by osteoblasts, features strikingly similar to those observed in cases ofsevere low-turnover human involutional osteoporosis. By 2 months of age, female and male Ick-IL-4 mice invariably developed severe osteoporosis of both cortical and trabecular bone. Osteoporosis was observed in two independently derived founder animals, indicating that this phenotype was directly mediated by the IL-4 transgene.
Maintaining skeletal bone mass is a dynamic process requiring a balance between bone resorption and formation (1) . After the completion of skeletal growth, involutional osteoporosis may occur if bone resorption by osteoclasts (e.g., as occurs during remodeling) exceeds bone production by osteoblasts (2) . Increased osteoclast activity and/or decreased osteoblast activity may contribute to the development of osteoporosis. Although involutional osteoporosis is a major cause of morbidity and mortality in developed countries (3), many issues regarding its pathogenesis and treatment remain unresolved.
A role for cytokines in the pathogenesis ofosteoporosis has been proposed since interleukin 1, interleukin 6, and tumor necrosis factor a enhance bone resorption in vitro (4) (5) (6) . The loss of estrogen production at the menopause accelerates osteoporosis in women, and it is intriguing that estrogen depletion by oophorectomy in mice causes an interleukin 6-dependent increase in trabecular bone osteoclasts (7) . The amount ofinterleukin 1 and tumor necrosis factor a produced by circulating mononuclear cells may also increase after oophorectomy in humans (8, 9) . Nevertheless, no direct evidence links increased production of these or other cytokines to the development of osteoporosis.
Interleukin 4 (IL-4) is a cytokine with pleiotropic effects on a wide variety of cell types (10) . We have reported (11) the generation of transgenic mice in which IL-4 expression was augmented in developing T-lineage cells by coupling the IL-4 cDNA to the proximal promoter of the Ick gene. Mice expressing the lck-IL-4 construct displayed perturbed T-cell development (11) . Here we show that lck-IL-4 mice also developed severe osteoporosis primarily because of a profound decrease in osteoblast activity. These results demon-
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" Whole-bone four-point bending tests to failure were conducted on a servo-hydraulic testing system at a constant displacement rate of 0.5 mm/sec (12, 13) . Micro-computed tomography was used to quantify the cross-sectional radius, moment of inertia, and cortical thickness of a 2-to 3-mm mid-diaphyseal region of femur specimens (13) . The scan region was divided into 20-,um sections, producing an average of 150 transverse sections for each femur. Images were thresholded to delineate each pixel as "bone" or "nonbone" (13) .
Histologic Analysis. For routine histologic analysis, the caudal vertebrae and bones of the hindlimbs were fixed in formalin, decalcified in 10% Na2EDTA (pH 6.9) and stained with hematoxylin and eosin. For histomorphometric analysis, mice received intraperitoneal injections of tetracycline as described (14) . After necropsy, bone tissue was fixed in formalin, dehydrated in acetone, embedded in methylacrylate, sectioned, stained by the modified Masson method, and histomorphometrically analyzed (15 (19) ], washed, and autoradiographed (11) .
Statistics. Values are presented as the mean ± SEM. Probabilities ofdifferences between transgenic and littermate control groups were determined using the unpaired two-tailed Student's t test unless otherwise indicated.
RESULTS
We observed that both sexes of one line of lck-IL-4 transgenic mice [line 1315 (11) ] became progressively humpbacked, starting between 3 and 6 months after birth. Radiography revealed kyphosis, an exaggerated curvature of the spine (Fig. 1A ), but no other signs of skeletal dysmorphism. Longitudinal growth occurred normally. Necropsied bones of lck-IL-4 mice of the 1315 line were semitranslucent, suggesting decreased bone mass. This abnormal skeletal appearance was invariably present in both transgenic females and males by 2 months of age and has remained stable during propagation of the 1315 line for 11 generations on a C57BL/6 genetic background. Microradiography revealed cortical thinning of the skeleton in lck-IL-4 mice, most striking in the long bones ( Fig. 1 B and C ). An analysis of four 3-month-old lck-IL-4 mice and four littermate controls demonstrated significant reduction in the mean cortical thickness and percent cortical area at the midshaft of the radius and ulna in the transgenic animals (data not shown). Bone disease was not explained by cachexia: The weights (mean ± SEM) for five 2-month-old male lck-IL-4 mice, all manifesting bone disease, and five male littermate controls were 23.5 ± 1.0 and 24.1 ± 0.4 g, respectively (P = 0.64).
IL-4 overexpression had a complex and dramatic influence on the mechanical properties and geometry of long bone in vivo (Table 1) . Both the stiffness (a measure of elastic deformation) and failure load (a measure of whole-bone bending strength) were significantly reduced in lck-IL-4 specimens. The anterior-posterior cross-section of lck-IL-4 femur specimens was significantly increased relative to controls, but the medial-lateral cross-section showed only a strong trend toward a significant increase. Thus, lck-IL-4 specimens had an increased cross-section and tended to be more round than oval (Fig. 1D) . These changes were not associated with a significant increase in the moment ofinertia (a measure of the geometrical resistance to bending) because the cortex of lck-IL-4 specimens was significantly thinner than normal. Histologic analysis demonstrated substantially decreased cortical and trabecular mass in the vertebral bodies as well as long bones from transgenic animals. Importantly, these decreases were seen in bone tissue from an independently derived lck-IL-4 founder animal, 4475, in which the transgene had presumably integrated at a different site than for the 1315 line ( Fig. 2 A and B) . These results indicated that the bone disease phenotype observed in lck-IL-4 mice resulted from lck-IL-4 transgene expression rather than a mutation produced by transgene integration.
Histologic analysis did not reveal an excess of unmineralized matrix in lck-IL-4 bone tissue ( Fig. 2A and B) , indicating that lck-IL-4 mice had an osteoporosis and not osteomalacia. Histologic and radiologic stigmata of other osteopenic disorders, including primary hyperparathyroidism and renal osteodystrophy, were also absent (data not shown). Transgenic and littermate-control animals had similar total serum calcium and protein levels ( Table 2 ), indicating that serumfree calcium levels were probably normal in lck-IL-4 mice, rather than elevated as is typical for primary hyperparathyroidism. lck-IL-4 sera also exhibited a small but significantly increased phosphate concentration. This excluded primary hyperparathyroidism since abnormally increased parathyroid hormone (PTH) secretion typically lowers serum phosphate levels (20) . Renal insufficiency in lck-IL-4 mice was excluded A D by the normal serum creatinine (Table 2 ) and normal microscopic renal histology (data not shown).
Osteoblasts in lck-IL-4 bone tissue were markedly atrophic ( Fig. 2 C and D (21) , were invariably found in lck-IL-4 sera ( Table 2 ). (ii) Profoundly decreased AP activity in situ was observed for osteoblasts lining the periosteum, endosteum, and trabeculae ( Fig. 2 E and F) . (iii) The percent of bone surface labeled in vivo was substantially reduced: In an experiment representative of results obtained with three litters, the percent total tetracycline surface for three 4-month-old lck-IL-4 mice and three littermate controls was 32.2 ± 3.7 and 49.0 ± 3.1, respectively (P < 0.05). These results characterize a state of decreased bone formation in the osteoporosis of lck-IL-4 mice.
Since IL-4 has been reported to inhibit in vitro osteoclastogenesis and osteoclast-mediated bone resorption (22) , bone tissue from lck-IL-4 mice was analyzed for osteoclast number and function. The number of osteoclasts per mm2 in the metaphyseal region of the tibia from four 3-month-old Ick-IL-4 and three littermate controls was 2.75 ± 0.69 and 1.92 + 0.05, respectively (P = 0.37), indicating that osteoclasto-. genesis probably occurred normally in transgenic animals. However, TRAP activity expressed by osteoclasts in situ was markedly reduced in lck-IL-4 bone tissue compared to osteoclasts in littermate control tissue (Fig. 2 G and H) , suggesting that osteoclast function was altered in lck-IL-4 mice.
Bone tissue from lck-IL-4 mice was also specifically examined for mast cell infitration, since IL-4 is a mast cell growth factor (23) and mastocytosis is a rare but welldocumented cause of human osteoporosis (24) . However, no mast cell infiltration of bone or soft tissues was found, indicating that mastocytosis did not mediate the bone disease of lck-IL-4 mice.
To determine whether a local action of IL-4 in mediating osteoporosis was plausible, bone marrow cells from transgenic mice and littermate controls were analyzed for expres- (Fig. 3A) . Consistent with earlier studies (11), IL-4 mRNA was also found in freshly isolated thymocytes and splenocytes from transgenic mice but not littermate controls and was also detected in an IL-4-producing T-cell line, EL-4. Similar amounts of 1-actin transcripts were detected in all RNA samples (Fig. 3B) , indicating that differences in IL-4 transcript abundance did not reflect variation in the efficiency of the RT reaction. No IL-4 or f-actin PCR products were detected in any RNA samples, including bone marrow RNA, when RT was omitted (Fig. 3, lanes 8-11) . Thus, the PCR products amplified from transgenic RNA samples did not reflect residual contaminating genomic DNA. These results suggest that the bone microenvironment of lck-IL-4 mice was exposed to higher levels of IL-4 than occur normally. DISCUSSION lck-IL-4 mice of both sexes displayed a generalized form of osteoporosis without evidence of other osteopenic disorders, such as osteomalacia, hyperparathyroidism, or renal osteodystrophy. Cortical thinning of the degree that occurred in lck-IL-4 mice has also been reported in cases of human osteoporosis (25) . The loss of trabecular bone in vertebral bodies, a particularly prominent feature in human involutional osteoporosis (2) , was also observed in lck-IL-4 animals. Although spontaneous fractures were not observed among 12 lck-IL-4 mice examined radiographically, bone mechanical integrity was decreased in these transgenic animals.
Cortical thinning is often accompanied by increased crosssectional geometry in individuals with osteoporosis (26) and was also observed in lck-IL-4 femur specimens. For lck-IL-4 femurs, the relationship between geometry and structural properties is complex because of the balancing effects of an increase in cross-section, a geometry that should increase mechanical properties, vs. a decrease in cortical thickness, which should decrease mechanical properties. Our data actually predict that lck-IL-4 specimens should have mechanical properties similar to controls (data not shown). However, the stiffness and failure load values for the transgenic specimens were significantly decreased ( (27) . IL-4 could compromise other biosynthetic functions mediated by osteoblasts, and it is known (12) that decreased production of type I collagen by osteoblasts can result in osteopenia, a form of osteogenesis imperfecta. However, the altered properties of lck-IL-4 specimens are not consistent with previous results obtained with the Movl3 murine model of osteogenesis imperfecta (12, 13): lck-IL-4 bone specimens showed decreased stiffness, whereas Movl3 specimens showed decreased plasticity in whole-bone bending tests to failure.
Our results indicate that the lck-IL-4 transgene does not significantly interfere with osteoclastogenesis, as has been observed in vitro (22) . However, our finding of markedly decreased osteoclast-associated TRAP activity suggests that osteoclast function is altered in lck-IL-4 mice. If the resorption of bone by osteoclasts is, like osteoclast-associated TRAP activity, reduced in lck-IL-4 mice, then the osteoporosis presumably results from a more severe decrease in osteoblast function relative to osteoclast function.
The mechanism for the modest hyperphosphatemia in lck-IL-4 mice remains uncertain. Preliminary studies indicate that PTH levels are modestly elevated in lck-IL-4 mice (D.B.L., unpublished observations), possibly in response to this hyperphosphatemia. IL4induced osteopenia is also unlikely to be due to secondary elevation of PIH since hyperparathyroidism is associated with increased numbers and activity of osteoclasts and osteoblasts (28) , the opposite of our findings in lck-IL-4 mice. Our results do not exclude the possibility that the skeletal tissue oflck-IL-4 mice may be resistant to the effects of PTH.
Regardless ofthe precise mechanism by which the Ick-IL-4 transgene acts to induce osteoporosis, the lck-IL-4 mouse may facilitate the evaluation of potential therapies to prevent or ameliorate bone loss. Intriguingly, osteoporosis is a common complication in patients with the hyper-IgE syndrome, a heritable immunodeficiency in which B lymphocytes function as if exposed to excess IL-4 (29) . Viewed in the context of the severe osteoporosis that develops in lck-IL-4 mice, this suggests that abnormalities in IL-4 production and/or IL-4-mediated signaling may alter osteoblast function and produce certain forms of human bone disease.
